Pritchard PH |
The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration. |
1987 |
Biochem. J. |
pmid:3689334
|
Hill CE and Olson MS |
Stimulation of uric acid release from the perfused rat liver by platelet activating factor or potassium. |
1987 |
Biochem. J. |
pmid:3689345
|
Bolin RW et al. |
Lung endothelial and epithelial permeability after platelet-activating factor. |
1987 |
J. Appl. Physiol. |
pmid:3693212
|
Smallbone BW et al. |
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep. |
1987 |
J. Pharmacol. Exp. Ther. |
pmid:2821222
|
Agrawal DK and Townley RG |
Effect of platelet-activating factor on beta-adrenoceptors in human lung. |
1987 |
Biochem. Biophys. Res. Commun. |
pmid:3030311
|
Hébert RL et al. |
Hemodynamic effects of PAF-acether on the dog kidney. |
1987 |
Prostaglandins Leukot Med |
pmid:3033688
|
Tysnes OB et al. |
Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets. |
1987 |
Biochem. Biophys. Res. Commun. |
pmid:3034251
|
Barnes PJ et al. |
The effect of platelet activating factor on pulmonary beta-adrenoceptors. |
1987 |
Br. J. Pharmacol. |
pmid:3034367
|
Gordeev KIu et al. |
[Synthesis of 1-(1-alkenyl)-2-acetyl-sn-glycero-3-phosphocholines, the aldehyded analogs of platelet activating factor]. |
1987 |
Bioorg. Khim. |
pmid:3566815
|
Davenas E et al. |
Effect of mouse peritoneal macrophages of orally administered very high dilutions of silica. |
1987 |
Eur. J. Pharmacol. |
pmid:3034632
|
Stahl GL and Lefer AM |
Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. |
1987 |
Blood Vessels |
pmid:3567363
|
Sigal CE et al. |
Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC). |
1987 |
J. Clin. Immunol. |
pmid:3571436
|
Godfroid JJ et al. |
Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity. |
1987 |
J. Med. Chem. |
pmid:3572968
|
Simon MF et al. |
Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. |
1987 |
Thromb. Res. |
pmid:3576518
|
Barrio V et al. |
Atrial natriuretic peptide inhibits glomerular contraction induced by angiotensin II and platelet activating factor. |
1987 |
Eur. J. Pharmacol. |
pmid:2952517
|
Kawasaki T and Snyder F |
The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla. |
1987 |
Biochim. Biophys. Acta |
pmid:3036238
|
Camussi G et al. |
Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. |
1987 |
J. Lab. Clin. Med. |
pmid:2955066
|
Foegh ML et al. |
Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2959038
|
Robertson DN and Smith GM |
Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2959049
|
d'Humieres S et al. |
Platelet activating factor acether is involved in thrombin-induced synthesis of prostacyclin by human endothelial cells. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2959051
|
Martin TR et al. |
Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. |
1987 |
J. Clin. Invest. |
pmid:2821074
|
Woodard DS et al. |
The final step in the de novo biosynthesis of platelet-activating factor. Properties of a unique CDP-choline:1-alkyl-2-acetyl-sn-glycerol choline-phosphotransferase in microsomes from the renal inner medulla of rats. |
1987 |
J. Biol. Chem. |
pmid:3029085
|
Chang SW et al. |
Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. |
1987 |
J. Clin. Invest. |
pmid:3553241
|
Saunders RN and Handley DA |
Platelet-activating factor antagonists. |
1987 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:3555317
|
Stafforini DM et al. |
Human plasma platelet-activating factor acetylhydrolase. Purification and properties. |
1987 |
J. Biol. Chem. |
pmid:3558407
|
Lapointe DS et al. |
Mobilization of hepatic calcium pools by platelet activating factor. |
1987 |
Biochemistry |
pmid:3593678
|
Fujita K et al. |
Synthesis and biological activity of fluorine-modified platelet activating factors. |
1987 |
Chem. Pharm. Bull. |
pmid:3594676
|
O'Neill C et al. |
Use of a bioassay for embryo-derived platelet-activating factor as a means of assessing quality and pregnancy potential of human embryos. |
1987 |
Fertil. Steril. |
pmid:3595903
|
Etienne A et al. |
Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity. |
1987 |
Int J Tissue React |
pmid:3596954
|
Doly M et al. |
Effects of PAF-acether on electrophysiological response of isolated retina. |
1987 |
Int J Tissue React |
pmid:3596955
|
Casals-Stenzel J |
Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis. |
1987 |
Immunopharmacology |
pmid:3597059
|
Ramesha CS and Pickett WC |
Fatty acid composition of diacyl, alkylacyl, and alkenylacyl phospholipids of control and arachidonate-depleted rat polymorphonuclear leukocytes. |
1987 |
J. Lipid Res. |
pmid:3106551
|
Dallob A et al. |
Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesia. |
1987 |
Biochem. Pharmacol. |
pmid:2822047
|
Purdon AD et al. |
Ionophore-stimulated rat basophilic leukemia cells produce PAF-acether. |
1987 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3100454
|
Wilcox RW et al. |
The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D. |
1987 |
Lipids |
pmid:3444369
|
Coëffier E et al. |
Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. |
1987 |
Br. J. Pharmacol. |
pmid:3118996
|
Kudo I et al. |
Antitumor activity of synthetic alkylphospholipids with or without PAF activity. |
1987 |
Lipids |
pmid:3444379
|
Hirafuji M et al. |
Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin. |
1987 |
Biochim. Biophys. Acta |
pmid:2888488
|
Brigham KL |
Conference summary: lipid mediators in the pulmonary circulation. |
1987 |
Am. Rev. Respir. Dis. |
pmid:2820285
|
Lamant V et al. |
Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. |
1987 |
Biochem. Pharmacol. |
pmid:2820421
|
Ramesha CS and Pickett WC |
Species-specific variations in the molecular heterogeneity of the platelet-activating factor. |
1987 |
J. Immunol. |
pmid:3100641
|
Codde JP et al. |
Can the synthesis of platelet-activating factor, a potent vasodilator and pro-aggregatory agent, be altered by dietary marine oils? |
1987 |
Clin. Exp. Pharmacol. Physiol. |
pmid:2822306
|
Makowka L et al. |
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. |
1987 |
Ann. Surg. |
pmid:3310931
|
Hanahan DJ and Kumar R |
Platelet activating factor; chemical and biochemical characteristics. |
1987 |
Prog. Lipid Res. |
pmid:3313430
|
Pignol B et al. |
Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes. |
1987 |
Prostaglandins |
pmid:3313526
|
Braquet P and Rola-Pleszczynski M |
The role of PAF in immunological responses: a review. |
1987 |
Prostaglandins |
pmid:3313527
|
Braquet P and Bourgain RH |
Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist. |
1987 |
Adv. Exp. Med. Biol. |
pmid:3314403
|
Di Marzo V et al. |
Platelet activating factor-mediated leukotriene biosynthesis in rat lungs: effect of prostaglandins E1 and F1 alpha. |
1987 |
Biochem. Biophys. Res. Commun. |
pmid:2822041
|
Vargaftig BB and Braquet PG |
PAF-acether today--relevance for acute experimental anaphylaxis. |
1987 |
Br. Med. Bull. |
pmid:2825900
|
Kochanek PM et al. |
Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia. |
1987 |
Life Sci. |
pmid:2826947
|
Murphy WG et al. |
Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura. |
1987 |
Br. J. Haematol. |
pmid:3499167
|
Suemune H et al. |
Asymmetric synthesis of (+)- and (-)-batyl alcohol, a key synthetic intermediate for platelet-activating factor, by using biocatalysts. |
1987 |
Chem. Pharm. Bull. |
pmid:3427701
|
Shimazaki N et al. |
Diketopiperazine derivatives, a new series of platelet-activating factor inhibitors. |
1987 |
Chem. Pharm. Bull. |
pmid:3427732
|
Lang CH et al. |
Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist. |
1987 |
Circ. Shock |
pmid:3427772
|
Korth R and Benveniste J |
BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets. |
1987 |
Eur. J. Pharmacol. |
pmid:3428349
|
Wymann MP et al. |
The onset of the respiratory burst in human neutrophils. Real-time studies of H2O2 formation reveal a rapid agonist-induced transduction process. |
1987 |
J. Biol. Chem. |
pmid:3040727
|
Bull HA and Machin SJ |
The haemostatic function of the vascular endothelial cell. |
1987 |
Blut |
pmid:3111566
|
Vane J and Botting R |
Inflammation and the mechanism of action of anti-inflammatory drugs. |
1987 |
FASEB J. |
pmid:3111928
|
Riedel A and Mest HJ |
The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites. |
1987 |
Prostaglandins Leukot Med |
pmid:3112804
|
Shimokawa H et al. |
Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. |
1987 |
Circ. Res. |
pmid:3113760
|
Adnot S et al. |
Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. |
1987 |
Agents Actions |
pmid:3115070
|
Livio M et al. |
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2823570
|
Stenzel H et al. |
Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. |
1987 |
Agents Actions Suppl. |
pmid:2823582
|
O'Flaherty JT and Wykle RL |
Metabolic origin and fate of platelet-activating factor. |
1987 |
Agents Actions Suppl. |
pmid:2823583
|
Gomez-Cambronero J et al. |
The diacylglycerol kinase inhibitor R59022 potentiates superoxide production but not secretion induced by fMet-Leu-Phe: effects of leupeptin and the protein kinase C inhibitor H-7. |
1987 |
Biochem. Biophys. Res. Commun. |
pmid:2823810
|
Bertani T et al. |
Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis. |
1987 |
Kidney Int. |
pmid:3039232
|
Morley J and Sanjar S |
PAF, ketotifen and asthma. |
1987 |
N. Z. Med. J. |
pmid:3468405
|
Abramovici Y et al. |
Control of the proliferation and differentiation of GEJ under platelet aggregating factor treatment. |
1987 |
Acta Endocrinol Suppl (Copenh) |
pmid:3475908
|
Krishnamurthi S et al. |
Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. |
1987 |
Biochim. Biophys. Acta |
pmid:3101746
|
Doebber TW and Wu MS |
Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils. |
1987 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:3478712
|
|
PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986. |
1987 |
Agents Actions Suppl. |
pmid:3478993
|
Liu BN |
[Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. |
1987 Jan-Feb |
Patol Fiziol Eksp Ter |
pmid:3550649
|
Lurie A et al. |
Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. |
1987 Jul-Aug |
Bull Eur Physiopathol Respir |
pmid:3690021
|
Auriault C et al. |
The effector function of platelets is induced and regulated by T lymphocytes. |
1987 Jul-Aug |
Ann. Inst. Pasteur Immunol. |
pmid:3118905
|
Fiedler VB et al. |
Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. |
1987 Mar-Apr |
Basic Res. Cardiol. |
pmid:3606544
|
Arnoux B et al. |
Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. |
1987 Mar-Apr |
Bull Eur Physiopathol Respir |
pmid:3607326
|
Berdel WE et al. |
Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. |
1987 Nov-Dec |
Anticancer Res. |
pmid:3442414
|
Lakin KM et al. |
[Action of calcium antagonists on thrombocyte aggregation]. |
1987 Sep-Oct |
Farmakol Toksikol |
pmid:2826225
|
Heptinstall S and Bevan J |
How can we inhibit 5-HT-induced platelet aggregation and why should we bother? |
1988 |
Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. |
pmid:2465956
|
Bodzenta-Lukaszyk A et al. |
Blood platelet function in patients with obliterative arteriosclerosis of the lower limbs. |
1988 |
Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. |
pmid:2465957
|
Levine L |
Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism. |
1988 |
Mol. Pharmacol. |
pmid:2849046
|
Nakamura T et al. |
Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages. |
1988 |
Eur. J. Pharmacol. |
pmid:2898372
|
Sessler CN et al. |
Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep. |
1988 |
J. Appl. Physiol. |
pmid:3145934
|
Del Monte M and Subissi A |
Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites. |
1988 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:3149718
|
Miyazawa K et al. |
Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species. |
1988 |
J. Immunol. |
pmid:3385211
|
Archer CB et al. |
Actions of platelet activating factor (PAF) homologues and their combinations on neutrophil chemokinesis and cutaneous inflammatory responses in man. |
1988 |
J. Invest. Dermatol. |
pmid:3385217
|
Pirotzky E and Braquet P |
PAF-acether and kidney pathology. |
1988 |
Prog Biochem Pharmacol |
pmid:3043431
|
Feuerstein G and Siren AL |
Platelet-activating factor and shock. |
1988 |
Prog Biochem Pharmacol |
pmid:3043432
|
Barr R et al. |
The effect of platelet activating factor on electron transport of spinach chloroplasts. |
1988 |
Biochem. Biophys. Res. Commun. |
pmid:3048258
|
Camussi G et al. |
Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. |
1988 |
J. Exp. Med. |
pmid:3049910
|
Chu KM et al. |
Local vasodilator effect of platelet activating factor in the gastric, mesenteric and femoral arteries of the dog. |
1988 |
J. Pharmacol. Exp. Ther. |
pmid:3418522
|
Pai JK et al. |
Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes. |
1988 |
Biochem. Biophys. Res. Commun. |
pmid:3422154
|
Braquet P et al. |
Platelet activating factor as a mediator in cerebral ischemia and related disorders. |
1988 |
Biomed. Biochim. Acta |
pmid:3073761
|
Wainwright CL et al. |
The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. |
1988 |
Biomed. Biochim. Acta |
pmid:3248108
|
Dembińska-Kieć A et al. |
Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed. |
1988 |
Biomed. Biochim. Acta |
pmid:3248109
|
Ostermann G et al. |
Structure-activity relationships of synthetic analogues of platelet-activating factor. |
1988 |
Biomed. Biochim. Acta |
pmid:3248110
|
Croft KD et al. |
The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats. |
1988 |
Clin. Exp. Pharmacol. Physiol. |
pmid:3271614
|
Kioumis I et al. |
Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. |
1988 |
Prostaglandins |
pmid:3237997
|
Sirois MG et al. |
PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. |
1988 |
Prostaglandins |
pmid:3238010
|
Fradin A et al. |
Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. |
1988 |
Biochim. Biophys. Acta |
pmid:2848583
|